Related Experiment Video
Updated: Jun 19, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2
1State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Abstract:
To elucidate the direct role and mechanism of FGFR1 signaling in the differentiation and activation of osteoclasts, we conditionally inactivated FGFR1 in bone marrow monocytes and mature osteoclasts of mice. Mice deficient in FGFR1 (Fgfr1(-/-)) exhibited misregulated bone remodeling with reduced osteoclast number and impaired osteoclast function. In vitro assay demonstrated that the number of tartrate-resistant acid phosphatase (TRAP) positive osteoclasts derived from bone marrow monocytes of Fgfr1(-/-) mice was significantly diminished. The bone resorption activity of mature osteoclasts derived from Fgfr1(-/-) mice was also suppressed. Further analysis showed that the osteoclasts with FGFR1 deficiency exhibited downregulated expression of genes related to osteoclastic activity including TRAP and MMP-9. The phosphorylation of Erk1/2 mitogen-activated protein (MAP) kinase was also decreased. Our results suggest that FGFR1 is indispensable for complete differentiation and activation of osteoclasts in mice.
Insights
Fibroblast growth factor receptor 1 (FGFR1) is essential for osteoclast differentiation and function. FGFR1 deficiency in mice impairs bone remodeling by reducing osteoclast number and activity.
Area of Science:
- Bone Biology
- Cell Signaling
- Skeletal Physiology
Background:
- Osteoclasts are critical for bone remodeling, and their dysfunction contributes to bone diseases.
- Fibroblast growth factor receptor 1 (FGFR1) signaling pathways are implicated in various cellular processes, but its specific role in osteoclast biology requires further elucidation.
Purpose of the Study:
- To investigate the direct role and underlying mechanisms of FGFR1 signaling in osteoclast differentiation and activation.
- To determine the impact of FGFR1 deficiency on bone remodeling in vivo and osteoclast function in vitro.
Main Methods:
- Conditional inactivation of FGFR1 in mouse bone marrow monocytes and mature osteoclasts.
- In vitro differentiation assays to assess osteoclast formation and tartrate-resistant acid phosphatase (TRAP) positive osteoclast counts.
- Bone resorption assays to evaluate the functional capacity of osteoclasts.
- Gene expression analysis (TRAP, MMP-9) and Western blotting for Erk1/2 mitogen-activated protein (MAP) kinase phosphorylation.
Main Results:
- Mice with FGFR1 deficiency (Fgfr1(-/-)) displayed dysregulated bone remodeling, characterized by a reduced number of osteoclasts and impaired osteoclast function.
- In vitro studies showed significantly diminished TRAP-positive osteoclast formation from Fgfr1(-/-) bone marrow monocytes.
- Bone resorption activity of mature osteoclasts from Fgfr1(-/-) mice was suppressed, with downregulated expression of key osteoclastic genes (TRAP, MMP-9) and decreased Erk1/2 MAP kinase phosphorylation.
Conclusions:
- FGFR1 signaling is indispensable for the complete differentiation and activation of osteoclasts.
- FGFR1 plays a crucial role in regulating osteoclast number, function, and the expression of genes vital for bone resorption.
- Targeting FGFR1 signaling may offer therapeutic potential for bone diseases associated with osteoclast dysfunction.
Related Concept Videos
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
MAPK Signaling Cascades
Introduction to Fibroblasts
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
